Russell Investments Group, Ltd. Amarin Corp Plcuk Transaction History

Russell Investments Group, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$5.03 - $8.8 $19,742 - $34,540	-3,925 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$3.64 - $7.76 $75,941 - $161,896	-20,863 Reduced 84.17%	3,925 $15,000
Q2 2020 Aug 05, 2020	BUY	$4.78 - $8.26 $8,871 - $15,330	1,856 Added 8.09%	24,788 $169,000
Q1 2020 May 06, 2020	BUY	$4.0 - $21.53 $2,980 - $16,039	745 Added 3.36%	22,932 $110,000
Q4 2019 Jan 29, 2020	BUY	$13.94 - $24.12 $19,474 - $33,695	1,397 Added 6.72%	22,187 $474,000

Q3 2019 Nov 01, 2019	BUY	$13.89 - $23.16 $288,773 - $481,496	20,790 New	20,790 $315,000

3.55M

36.9K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $6.59B
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.